OPA1 and optic atrophy: A fission yeast msp1 mutant, which is defective in dynamin GTPase, required for mitochondrial fusion and mitochondrial DNA maintenance, has been employed to screen repurposed drugs for a potential remedy for optic atrophy caused by mutations in OPA1, the human orthologue of msp1 [73].